BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13725632)

  • 1. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3,5-pyrazolidinedione. 2. Practical performance of the investigations].
    ECKSTEIN M; LINDNER J; von SCHWEINITZ H
    Arzneimittelforschung; 1960 Nov; 10():902-9. PubMed ID: 13725632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3, 5-pyrazolidine-dione. 1. Theoretical basis].
    von SCHWEINITZ H; LINDNER J; ECKSTEIN M
    Arzneimittelforschung; 1960 Nov; 10():899-901. PubMed ID: 13749227
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the antineoplastic effect of the components of ground substance. Part 3. The relation between survival rates, metabolism studies and cytological findings].
    von SCHWEINITZ H; LINDNER J; VOSS H
    Frankf Z Pathol; 1960; 70():550-67. PubMed ID: 13831251
    [No Abstract]   [Full Text] [Related]  

  • 4. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on the action of 4-butyl-1,2-diphenyl-3, 5-pyrazolidinedione on embryonal fibroblasts, blood and bone marrow cells in vitro].
    ALBRECHT M; ESCHENBACH J; KRETSCHMER V
    Arzneimittelforschung; 1960 Aug; 10():606-12. PubMed ID: 13682160
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the structure and function of connective tissue. 5. Differentiation of tendon connective tissue during growth and its modification by desmotropic pharmacological agents].
    FICK K; GATTOW G; HARTMANN F; SCHWARZ W
    Z Rheumaforsch; 1960 Oct; 19():293-310. PubMed ID: 13699310
    [No Abstract]   [Full Text] [Related]  

  • 8. Facile synthesis of high specific activity 4-[1-
    Singh A; Hakk H; Lupton SJ
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):386-390. PubMed ID: 29274290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].
    BEHRE R
    Arzneimittelforschung; 1958 Aug; 8(8):520-5. PubMed ID: 13584244
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the pharmacology of 1-phenyl-2,3-dimethyl-4-isopropylaminopyrazolone (isopyrin) and 1,2-diphenyl-4-butyl-3,5-pyradolidinedione (phenylbutazone)].
    SCHOETENSACK W; RICHARZ G; BISCHLER P
    Arzneimittelforschung; 1960 Aug; 10():665-76. PubMed ID: 13748426
    [No Abstract]   [Full Text] [Related]  

  • 11. [On an iodinated derivative of 1,2-diphenyl-4-n-butyl-3,5-pyrazolidinedione].
    CONTI L
    Farmaco Prat; 1961 May; 16():240-3. PubMed ID: 13695183
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of protracted halothane-nitrous-oxide anesthesia on granuloma development in the rat].
    Cunitz G; Weis KH
    Anaesthesist; 1971 Feb; 20(2):55-6. PubMed ID: 5544908
    [No Abstract]   [Full Text] [Related]  

  • 13. [On changes in sulfomucopolysaccharide metabolism in the connective tissue under the effects of infection and sensitization].
    HAUSS WH; JUNGE-HUELSING G; STROBEL W
    Z Rheumaforsch; 1960 Jun; 19():161-6. PubMed ID: 13712341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine on phosphatases. 2].
    OHLMEYER P; KROMER H
    Arzneimittelforschung; 1958 Apr; 8(4):247-8. PubMed ID: 13535368
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine on phosphatases].
    HAHN E; PLATE B
    Arzneimittelforschung; 1956 Dec; 6(12):728-9. PubMed ID: 13395936
    [No Abstract]   [Full Text] [Related]  

  • 16. Homeostasis of connective tissues. I. Calcium-sodium equilibrium.
    ENGEL MB; JOSEPH NR; CATCHPOLE HR
    AMA Arch Pathol; 1954 Jul; 58(1):26-39. PubMed ID: 13170901
    [No Abstract]   [Full Text] [Related]  

  • 17. [The problem of phanerosis of acid mucopolysaccharides in the connective tissue].
    BRAUN-FALCO O
    Dermatol Wochenschr; 1959 Feb; 139(6):129-35. PubMed ID: 13652560
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione).
    BRODIE BB; YU TF; BURNS JJ; CHENKIN T; PATON BC; STEELE JM; GUTMAN AB
    Proc Soc Exp Biol Med; 1954; 86(4):884-7. PubMed ID: 13204385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the chemistry of the arterial wall. III. Changes in the connective tissue of the aorta and influences in experimental arteriosclerosis of animals].
    BUDDECKE E
    Hoppe Seylers Z Physiol Chem; 1958; 310(3-6):199-212. PubMed ID: 13548893
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the chemistry of the arterial wall. II. Arteriosclerotic changes in connective tissue of aorta in man].
    BUDDECKE E
    Hoppe Seylers Z Physiol Chem; 1958; 310(3-6):182-98. PubMed ID: 13548892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.